Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Unknown 4Recruiting 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 682Urinary Bladder Neoplasms 249Carcinoma, Renal Cell 188Kidney Neoplasms 94Neoplasms 71Carcinoma, Transitional Cell 68Breast Neoplasms 65Lung Neoplasms 37Ovarian Neoplasms 36Melanoma 36Stomach Neoplasms 35Non-Muscle Invasive Bladder Neoplasms 35Colorectal Neoplasms 35Neoplasm Metastasis 33Pancreatic Neoplasms 30Carcinoma, Non-Small-Cell Lung 28Recurrence 26Colonic Neoplasms 24Urologic Neoplasms 20Testicular Neoplasms 20Uterine Cervical Neoplasms 19Esophageal Neoplasms 19Head and Neck Neoplasms 18Disease 18Wilms Tumor 17Carcinoma, Hepatocellular 17Liver Neoplasms 16Prostatic Hyperplasia 15Endometrial Neoplasms 15Sarcoma 14

Interventions

toripalimab 1tislelizumab 1liposomal doxorubicin 1disitamab vedotin 1RC48 antibody 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Muscle Invasive Bladder Cancer × Genitourinary × Clear all
NCT05979740 2023-08-31

RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBC

RenJi Hospital

Phase 2 Unknown
6 enrolled
Genitourinary

Muscle Invasive Bladder Cancer

NCT04813107 2022-02-22

ANTICIPATE

Jiangsu Yahong Meditech Co., Ltd aka Asieris

Phase 1/2 Unknown
79 enrolled
Genitourinary

Muscle Invasive Bladder Cancer

NCT04101812 2019-09-26

Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer

Tianjin Medical University Second Hospital

Phase 2 Unknown
60 enrolled
Genitourinary

Muscle Invasive Bladder Cancer

NCT02648100 2017-06-20

DIATRIBBE

Assistance Publique - Hôpitaux de Paris

Unknown
911 enrolled
Genitourinary

Muscle Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡